2-amino-3-(alkyl)-pyrimidone derivatives

Details 2-amino-3-(alkyl)-pyrimidone derivatives 2-amino-3-(alkyl)-pyrimidone derivatives

2008-05-27

2008-05-27

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S211150, C514S272000, C514S273000, C540S544000, C540S575000, C544S320000, C544S321000

Reexamination Certificate

active

11035264

ABSTRACT:
A pyrimidone derivative represented by formula (I) or a salt thereof:Wherein:R1 represents a hydrogen atom or a C1-6alkyl group which may be substituted by a C6,10aryl group;R2 represents a C1-10alkyl group which may be substituted, a C2-6alkenyl group which may be substituted, a C3-6alkynyl group which may be substituted, a C3-6cycloalkyl group which may be substituted, or a C6-10ARYL group which may be substituted;or R1 and R2 form together a C2-6alkylene group which may be substituted;or R1 and R2 form together a chain of formula —(CH2)2—X—(CH2)2— or —(CH2)2—X—(CH2)3— where X represents a oxygen atom, a sulfur atom, or a nitrogen atom which may be substituted;R3 represents a 2, 3 or 4-pyridyl group optionally substituted by a C1-4alkyl group, C1-4alkoxy group or halogen atom; andR4 represents a C1-10alkyl group optionally substituted by a hydroxyl group, amino, C1-6monoalkylamino group, C2-12dialkylamino group or C6,10aryl group which may be substituted.And a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3β such as Alzheimer's disease.

REFERENCES:
patent: 4460589 (1984-07-01), Wierenga et al.
patent: 6844335 (2005-01-01), Almario Garcia et al.
patent: 07 435631 (1974-09-01), None
patent: 07 435633 (1974-09-01), None
patent: WO 98 24780 (1998-06-01), None
patent: WO 00 18758 (2000-04-01), None
Ulrich, Crystallization—4. Crystal Characteristics, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
Vippagunta et al., Crystalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
Julien et al., PubMed Abstract (Prog Nucleic Acid Res Mol Biol. 61:1-23), 1998.
Liu et al., PubMed Abstract (J Neurochem 87(6):1333-44), Dec. 2003.
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20th Edition, vol. 2, pp. 1992-1996, 1996.
Layzer, Degenerative Diseases of the Nervous System, Cecil Textbook of Medicine, 20th Edition, vol. 2, pp. 2050-2057, 1996.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1010, 1996.
Chemical Abstracts, vol. 84, No. 7, Feb. 16, 1976, Columbus, OH, p. 502, Abstract No. 44112b.
Chemical Abstracts, vol. 83, No. 1, Jul. 7, 1975, Columbus, OH, p. 853, Abstract No. 10127z.
H.I. Skulnick, et al.; “Pyrimidinones.3.N-Substituted 6-Phenylpyrimidinones and Pyrimidinediones with Diuretic/Hypotensive and Antiinflammatory Activity”; J. Med. Chem., vol. 29, No. 8, 1986, pp. 1499-1504.
H.I. Skulnick, et al.; “Pyrimidinones.1.2 Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-Inducing Antiviral Agents”; J. Med. Chem., vol. 28, No. 12, 1985, pp. 1864-1869.
H.J. Kabbe; “Substituierte 4-Hydroxy-und 4-Amino-pyrimidine”; Liebigs Ann. Chem.; vol. 704; 1967; pp. 144-149.

Affiliated with

Also associated with

Rating

2-amino-3-(alkyl)-pyrimidone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-amino-3-(alkyl)-pyrimidone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-amino-3-(alkyl)-pyrimidone derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3907107